FHIR IG analytics| Package | hl7.fhir.uv.clinical-study-protocol |
| Resource Type | ResearchStudy |
| Id | ResearchStudy-Exemplar-ResearchStudy-Current-Amendment.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ResearchStudy Exemplar-ResearchStudy-Current-Amendment
Language: en
Profile: M11 Research Study Profile
M11 Research Study Extension
- originalProtocol: Protocol Previously Amended See Summary of Changes Before the Table of Contents
- versionDate: 2017-10-01
M11_Approval
- approvalDate: 2017-10-05
- signature: No display for Signature (data: 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)
- signatureUrl: https://somelocation
- signatureMethod: electronic and wet ink copy
M11_ProtocolAmendment
url
identifiervalue: Amendment Identifier/ABC-Exemplar(a)
url
previousvalue: Protocol Previously Amended See Summary of Changes Before the Table of Contents
url
scopevalue: Not Global
url
Country ValueSetvalue: Germany
url
Country ValueSetvalue: United Kingdom of Great Britain and Northern Ireland
url
regionvalue: New South Wales
url
sitevalue:
https://example.org/site-identifier/exemplarSite-14scope: Locally
number: 234
url
M11_AmendmentScopeImpactscope: Global
number: 983
url
M11_AmendmentScopeImpacturl
primaryReasonvalue: Regulatory Agency Request to Amend Amendment Reason
url
secondaryReasonvalue: Manufacturing Change Amendment Reason
url
secondaryReasonvalue: Packaging revision
url
summaryvalue: Manufacturing chanage to enable packaging change to recyclable materials.
url
substantialImpactSafetyvalue: Yes
url
substantialImpactSafetyCommentvalue: Specifically implemented to decrease safety risks.
url
substantialImpactReliabilityvalue: No
detail: Clarification
rationale: Clarification of synopsis at request of regulator
section: ICH M11 Protocol Section 1.1 Protocol Synopsis
url
M11_AmendmentDetailsdetail: Exclusion change
rationale: Exclude regular drinkers at request of regulator
section: ICH M11 Protocol Section 5.3 Exclusion Criteria
url
M11_AmendmentDetailsdetail: Packaging change
rationale: Change to recyclable packaging (stated in proprietary name).
section: ICH M11 Protocol Section Title Page
url
M11_AmendmentDetailsurl
descriptionvalue:
#Protocol ABC-Exemplar A Phase 3 Study of Inhaled Exoticillin compared to Intramuscular Exoticillin for Treatment of Bronchtis Japanese Patients with Iatrogenic Diabetes Mellitus has been amended. The new protocol is indicated by Amendment (a) and will be used to conduct the study in place of any preceding version of the protocol. The overall changes and rationale for the changes made to this protocol are as follows: - An exclusion criterion for patients with retinopathy or maculopathy was added due to the potential risk of fundal hemorrhage induced by hypoglycemia. - The Intravenous Exoticillin GlucaGen reconstitution volume was changed from 1.0 mL to 1.1 mL in accordance with instructions in the Summary of Product Characteristics (2015).
identifier: Sponsor Protocol Identifier/ABC-Exemplar (use: usual, )
version: (a)
status: Active
{
"resourceType": "ResearchStudy",
"id": "Exemplar-ResearchStudy-Current-Amendment",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-research-study-profile"
]
},
"language": "en",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"extension": [
{
"url": "originalProtocol",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218488",
"display": "Protocol Previously Amended See Summary of Changes Before the Table of Contents"
}
]
}
},
{
"url": "versionDate",
"valueDate": "2017-10-01"
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-research-study"
},
{
"extension": [
{
"url": "approvalDate",
"valueDate": "2017-10-05"
},
{
"url": "signature",
"valueSignature": {
"data": "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"
}
},
{
"url": "signatureUrl",
"valueUrl": "https://somelocation"
},
{
"url": "signatureMethod",
"valueString": "electronic and wet ink copy"
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-approval"
},
{
"extension": [
{
"url": "identifier",
"valueIdentifier": {
"type": {
"text": "Amendment Identifier"
},
"system": "https://example.org/amendment-identifier",
"value": "ABC-Exemplar(a)"
}
},
{
"url": "previous",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218488",
"display": "Protocol Previously Amended See Summary of Changes Before the Table of Contents"
}
]
}
},
{
"url": "scope",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C217026",
"display": "Not Global"
}
]
}
},
{
"url": "country",
"valueCodeableConcept": {
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "DE",
"display": "Germany"
}
]
}
},
{
"url": "country",
"valueCodeableConcept": {
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "GB",
"display": "United Kingdom of Great Britain and Northern Ireland"
}
]
}
},
{
"url": "region",
"valueCodeableConcept": {
"coding": [
{
"system": "urn:iso:std:iso:3166:-2",
"code": "AU-NSW",
"display": "New South Wales"
}
]
}
},
{
"url": "site",
"valueIdentifier": {
"system": "https://example.org/site-identifier",
"value": "exemplarSite-14"
}
},
{
"extension": [
{
"url": "scope",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C41065",
"display": "Locally"
}
]
}
},
{
"url": "number",
"valuePositiveInt": 234
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-amendment-scope-impact"
},
{
"extension": [
{
"url": "scope",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C68846",
"display": "Global"
}
]
}
},
{
"url": "number",
"valuePositiveInt": 983
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-amendment-scope-impact"
},
{
"url": "primaryReason",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218490",
"display": "Regulatory Agency Request to Amend Amendment Reason"
}
]
}
},
{
"url": "secondaryReason",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218494",
"display": "Manufacturing Change Amendment Reason"
}
]
}
},
{
"url": "secondaryReason",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C17649",
"display": "Other"
}
],
"text": "Packaging revision"
}
},
{
"url": "summary",
"valueString": "Manufacturing chanage to enable packaging change to recyclable materials."
},
{
"url": "substantialImpactSafety",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C49488",
"display": "Yes"
}
]
}
},
{
"url": "substantialImpactSafetyComment",
"valueString": "Specifically implemented to decrease safety risks."
},
{
"url": "substantialImpactReliability",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C49487",
"display": "No"
}
]
}
},
{
"extension": [
{
"url": "detail",
"valueString": "Clarification"
},
{
"url": "rationale",
"valueString": "Clarification of synopsis at request of regulator"
},
{
"url": "section",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218515",
"display": "ICH M11 Protocol Section 1.1 Protocol Synopsis"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-amendment-detail"
},
{
"extension": [
{
"url": "detail",
"valueString": "Exclusion change"
},
{
"url": "rationale",
"valueString": "Exclude regular drinkers at request of regulator"
},
{
"url": "section",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218550",
"display": "ICH M11 Protocol Section 5.3 Exclusion Criteria"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-amendment-detail"
},
{
"extension": [
{
"url": "detail",
"valueString": "Packaging change"
},
{
"url": "rationale",
"valueString": "Change to recyclable packaging (stated in proprietary name)."
},
{
"url": "section",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C222769",
"display": "ICH M11 Protocol Section Title Page"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-amendment-detail"
},
{
"url": "description",
"valueMarkdown": "#Protocol ABC-Exemplar A Phase 3 Study of Inhaled Exoticillin compared to Intramuscular Exoticillin for Treatment of Bronchtis Japanese Patients with Iatrogenic Diabetes Mellitus\n has been amended.\n The new protocol is indicated by *Amendment (a)* and will be used to conduct the study in place of any preceding version of the protocol. \n The overall changes and rationale for the changes made to this protocol are as follows: \n - An exclusion criterion for patients with retinopathy or maculopathy was added due to the potential risk of \n fundal hemorrhage induced by hypoglycemia. \n - The Intravenous Exoticillin GlucaGen reconstitution volume was changed from 1.0 mL to 1.1 mL in accordance with instructions in the Summary of Product Characteristics (2015)."
}
],
"url": "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-protocol-amendment"
}
],
"identifier": [
{
"use": "usual",
"type": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C132351",
"display": "Sponsor Protocol Identifier"
}
]
},
"system": "https://exemplarSponsor.com/sponsor-identifier",
"value": "ABC-Exemplar"
}
],
"version": "(a)",
"status": "active"
}